GlassScriptPhysician profile
Pamela C Bryant
NPI 1548694169
$1,730.14
in general payments reported to CMS, 2019-2025
16 companies · $211 in 2025
The $211 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $466 · 2023: $551 · 2024: $503 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,264.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $219.85 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $216.84 | 2022-2023 | Evkeeza |
| Abbott Laboratories | $184.88 | 2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Otsuka America Pharmaceutical, INC. | $143.46 | 2024 | Rexulti, Abilify Maintena |
| Madrigal Pharmaceuticals | $142.45 | 2024 | Rezdiffra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.52 | 2023 | |
| Shield Therapeutics INC | $124.49 | 2022 | |
| Mayne Pharma Commercial LLC | $116.55 | 2023 | |
| Biogen, INC. | $114.19 | 2025 | Zurzuvae |
| Aspira Women'S Health INC | $97.64 | 2024 | Ova1 |
| Exact Sciences Corporation | $96.88 | 2025 | Cologuard Collection Kit |
| Alkermes, INC. | $43.47 | 2024 | Aristada, Lybalvi |
| Teva Pharmaceuticals USA, INC. | $37.73 | 2024 | Uzedy |
| Abbvie INC. | $29.34 | 2023 | |
| Janssen Pharmaceuticals, INC | $19.73 | 2024 | Spravato |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $18.12 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pamela Bryant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.